Talat Imran
CEO at Rani Therapeutics Holdings Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Rani Therapeutics Holdings Inc., 3 years.
Rani Therapeutics Holdings Inc.
Director · Chief Executive Officer
Chief executive roles
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 17, 2026 | Rani Therapeutics Holdings Inc. | Open-market purchase | +35,000 | $0.72 | $25,193 |
| Jun 27, 2026 | Rani Therapeutics Holdings Inc. | Shares withheld for tax | −7,927 | $0.74 | $5,866 |
| Mar 27, 2026 | Rani Therapeutics Holdings Inc. | Shares withheld for tax | −9,099 | $0.81 | $7,370 |
| Mar 22, 2026 | Rani Therapeutics Holdings Inc. | Shares withheld for tax | −8,916 | $1.13 | $10,075 |
| Dec 27, 2025 | Rani Therapeutics Holdings Inc. | Shares withheld for tax | −7,906 | $1.40 | $11,068 |
| Sep 27, 2025 | Rani Therapeutics Holdings Inc. | Shares withheld for tax | −9,077 | $0.48 | $4,357 |
| Jun 27, 2025 | Rani Therapeutics Holdings Inc. | Shares withheld for tax | −9,076 | $0.55 | $4,992 |
| Dec 27, 2024 | Rani Therapeutics Holdings Inc. | Open-market sale | −8,014 | $1.41 | $11,300 |
| Dec 9, 2024 | Rani Therapeutics Holdings Inc. | Open-market purchase | +10,296 | $1.94 | $19,974 |
| Dec 6, 2023 | Rani Therapeutics Holdings Inc. | Open-market purchase | +10,000 | $2.27 | $22,700 |
| Dec 4, 2023 | Rani Therapeutics Holdings Inc. | Open-market purchase | +5,000 | $2.57 | $12,850 |
| Nov 29, 2023 | Rani Therapeutics Holdings Inc. | Open-market purchase | +20,000 | $2.05 | $41,000 |
| Nov 7, 2023 | Rani Therapeutics Holdings Inc. | Open-market purchase | +2,500 | $1.98 | $4,950 |
| Nov 7, 2023 | Rani Therapeutics Holdings Inc. | Open-market purchase | +2,500 | $2.01 | $5,025 |
| Mar 27, 2023 | Rani Therapeutics Holdings Inc. | Grant or award | +353,500 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.